Differences in injectable platelet-rich fibrin fraction of peripheral blood on the release of TGF-β1 and PDGF-AB

Suryono Suryono; Arifia Anindita Danastri

doi:10.22146/majkedgiind.81482

Differences in injectable platelet-rich fibrin fraction of peripheral blood on the release of TGF-β1 and PDGF-AB

https://doi.org/10.22146/majkedgiind.81482

Suryono Suryono^(1*), Arifia Anindita Danastri⁽²⁾

(1) Department of Periodontics, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(2) Clinical Dentistry Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract

Injectable platelet-rich fibrin (i-PRF) refers to second-generation platelet concentrate. In this study, the results of i-PRF centrifugation were fractionated into three layers: yellow i-PRF, buffy coat, and red i-PRF. Injectable platelet-rich fibrin fractions used in this study were yellow i-PRF, red i-PRF, and a mix of both. This study aimed to examine the level of growth factor release of transforming growth factor beta 1 (TGF-β1) and platelet-derived growth factor (PDGF) in yellow i-PRF, red i-PRF, and a mix of yellow i-PRF and red i-PRF with the ratio of 1:1. A total of 10 ml of peripheral blood from healthy female donors was centrifuged (at 700 rpm in 3 minutes) to obtain i-PRF and fractionated into three layers. The upper yellow layer was taken as yellow i-PRF, while the bottom red layer was taken as red i-PRF and was taken together with the middle layer (buffy coat). The release of TGF-β1 and PDGF in each of i-PRF fractionation method, i.e. yellow i-PRF, red i-PRF, and a mix of yellow i-PRF and red i-PRF with a ratio of 1:1 was measured with ELISA. The measurement was observed for 24 hours, 3 days, 7 days, 10 days, and 14 days. Data analysis used the two-way ANOVA test with a significance level of 0.05 and a post hoc LSD analysis to establish group significance. The group of yellow + red i-PRF significantly released PDGF-AB (p < 0.05). TGF-β1 was the highest of all groups on day 14. All groups showed an increase in growth factor release from time to time. The fractionation method of injectable platelet-rich fibrin affected the release of growth factor of PDGF-AB and TGF-β1. The highest release of PDGF-AB and TGF-β1 was found in the yellow + red i-PRF group with a ratio of 1:1 in the 14-day group, which was significant with the other two groups (p < 0.05).

Keywords

fractionation; injectable platelet-rich fibrin; platelet-derived growth factor; transforming growth factor beta 1

Full Text:

PDF

References

1. Miyata Y, Obata Y, Mochizuki Y, Kitamura M, Mitsunari K, Matsuo T, Ohba K, Mukae H,
Nishino T, Yoshimura A, Sakai H. Periodontal disease in patients receiving dialysis. Int J Mol
Sci. 2019; 20(3805): 1-21. doi: 10.3390/ijms20153805

2. Siaili M, Chatzopoulou D, Gillam DG. An overview of periodontal regenerative
procedures for the general dental practitioner. Saudi Dent J. 2018; 30(1): 26-37.
doi: 10.1016/j.sdentj.2017.11.001

3. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers.
2017; 3(17038): 1-14. doi: 10.1038/nrdp.2017.38

4. Suchetha A, Lalwani M, Darshan BM, Sapna N, Bhat D, Sravani K. Growth factors: role in
periodontal regeneration. Journal of Research in Medical and Dental Science. 2015; 3(3):
166-70. doi: 10.5455/jrmds.2015332

5. Feigin K, Shope B. Use of platelet-rich plasma and platelet-rich fibrin in dentistry and
oral surgery: introduction and review of the literature. J Vet Dent. 2019; 36(2): 109-123.
doi: 10.1177/0898756419876057

6. Thanasrisuebwong P, Surarit R, Bencharit S, Ruangsawasdi N. Influence of fractionation
methods on physical and biological properties of injectable platelet-rich fibrin: an exploratory
study. Int J Mol Sci. 2019; 20(7): 1657. doi: 10.3390/ijms20071657

7. Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Injectable Platelet Rich Fibrin (i-PRF): opportunities in regenerative dentistry?. Clin Oral Invest. 2017; 21(8): 2619-2627. doi: 10.1007/s00784-017-2063-9

8. Varela HA, Souza JCM, Nascimento RM, Araujo JrRF, Vasconcelos RC, Cavalcante
RS, Guedes PM, Araujo AA. Injectable platelet rich fibrin: cell content, morphological, and
protein characterization. Clin Oral Investig. 2019; 23(3): 1309-1318. doi: 10.1007/s00784-018-2555-2

9. Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J.
Optimized platelet-rich fibrin with the lowspeed concept: growth factor release,
biocompatibility, and cellular response. J Periodontol. 2017; 88(1): 112-121.
doi: 10.1902/jop.2016.160443

10. Choukroun J, Ghanaati S. Reduction of relative centrifugation force within injectable plateletrich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and
growth factors: the first introduction to the lowspeed centrifugation concept. Eur J Trauma
Emerg Surg. 2018; 44(1): 87–95. doi: 10.1007/s00068-017-0767-9

11. Gollapudi M, Bajaj P, Oza RR. Injectable platelet-rich fibrin - a revolution in periodontal
regeneration. Cureus. 2022; 14(8): e28647. doi: 10.7759/cureus.28647

12. Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable plateletrich
fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich
plasma. Platelets. 2018; 29(1): 48-55. doi: 10.1080/09537104.2017.1293807

13. Mourão CF, Valiense H, Melo ER, Mourão NB, Maia MD. Obtention of injectable platelets
rich-fibrin (i-PRF) and its polymerization with bone graft: technical note. Rev Col Bras Cir.
2015; 42(6): 421-423. doi: 10.1590/0100-69912015006013

14. Ozsagir ZB, Saglam E, Sen Yilmaz B, Choukroun J, Tunali M. Injectable plateletrich
fibrin and microneedling for gingival augmentation in thin periodontal phenotype:
A randomized controlled clinical trial. J Clin Periodontol. 2020; 47(4): 489-499.
doi: 10.1111/jcpe.13247

DOI: https://doi.org/10.22146/majkedgiind.81482